Sort
23,748 grants matching “melanoma”
CONTROL OF DENDRITIC CELL GENERATION &FUNCTION BY TUMOR
$222,171University Of Pittsburgh At Pittsburgh · R01 · FY2002 · CA
Imaging the Effects of Inhibition of Oncogene Signaling on Tumor Growth and....
$222,094Steven M Larson · Sloan-Kettering Inst Can Research · P50 · FY2012 · CA
Core 2: Computational and Data Integration
$222,081Kelly Valentine Ruggles · New York University School Of Medicine · U54 · FY2022 · CA
Dinuclear Ruthenium Complexes for Cancer Treatment
$222,000Frederick M Macdonnell · University Of Texas Arlington · R15 · FY2006 · CA
North Central Cancer Treatment Group
$222,000Jan C Buckner · Mayo Clinic Rochester · U10 · FY2007 · CA
Psoralens and melanoma
$221,938Eunyoung Cho · Brown University · R21 · FY2015 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$221,903Bin Zhang · Northwestern University At Chicago · R01 · FY2021 · CA
TRAINING IN IMMUNODERMATOLOGY
$221,893University Of Colorado Denver · T32 · FY2003 · AR
Discovering modulators of exonucleases PLD3 and PLD4 for immunoregulation
$221,875Kim D Janda · Scripps Research Institute, The · R21 · FY2023 · AI
FUNCTION AND REGULATION OF CD/RAP
$221,865Barnes-Jewish Hospital · R01 · FY2002 · AR
P38 MAP Kinase/P1-3 Kinase for Chemoprevention of Cancer
$221,836University Of Arizona · P01 · FY2004 · CA
Regulation of Wnt Gradient Formation by Palmitoylation
$221,755Laura W. Burrus · San Francisco State University · S06 · FY2010 · GM
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$221,727Neeha Zaidi · Johns Hopkins University · K08 · FY2021 · CA
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$221,727Neeha Zaidi · Johns Hopkins University · K08 · FY2023 · CA
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$221,727Neeha Zaidi · Johns Hopkins University · K08 · FY2022 · CA
Neoantigen-Targeted Vaccines in Combination with Immune Checkpoint Inhibitors for Pancreatic Cancer
$221,727Neeha Zaidi · Johns Hopkins University · K08 · FY2024 · CA
MATCHMAKERS - Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches
$221,655Peter Michael Bruno · University Of California, San Francisco · OT2 · FY2025 · CA
Invasive Behavior of Tumor Cells Producing Collagenase-1
$221,598Constance E Brinckerhoff · Dartmouth College · R01 · FY2013 · CA
Melanoma prevention by MC1R selective small peptide analogs of alpha MSH
$221,595Zalfa Abdel-Malek · University Of Cincinnati · R21 · FY2015 · CA
Metabotropic Glutamate Receptor 1 in African American Prostate Cancer
$221,589Shahriar Koochekpour · Roswell Park Cancer Institute Corp · R21 · FY2014 · CA
TARGETED NANOCARRIER FOR SIRNA DELIVERY TO TUMOR VASCULATURE
$221,574Joseph Anthoney Vetro · University Of Nebraska Medical Center · P20 · FY2009 · RR
Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases: Avoidance of Eloquent White Matter and Hippocampal Regions
$221,479Jona A Hattangadi-Gluth · University Of California, San Diego · R01 · FY2021 · CA
Regulation of PD-1 as a strategy against chronic HIV-1 infection
$221,370Li Huang · Duke University · R21 · FY2013 · AI
HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER
$221,345Battelle Pacific Northwest Laboratories · R21 · FY2000 · CA
Cancer Genetics
$221,343Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2014 · CA